Fu Kang Yang bought 1.06 billion shares of JINHAI MED TECH off-exchange at an average of HKD 2.5000 per share on November 6, 2026, involving about HKD 2.64 billion; it was an off-exchange transaction (nature of consideration: cash), not matched on the SEHK open market and therefore not a direct secondary-market dealing.
Prior to the acquisition, Fu Kang Yang’s long position in JINHAI MED TECH was 0 shares, representing 0.0%; following the acquisition, the holding changed to 1.06 billion shares, with the long position ratio rising to 19.86%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments